Cyclerion Therapeutics (CYCN) Operating Expenses (2018 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Operating Expenses of $1.9 million for Q3 2025, up 42.28% year-over-year from $1.3 million in Q3 2024, and up 6.57% quarter-over-quarter from $1.8 million in Q2 2025.
Cyclerion Therapeutics (CYCN) Operating Expenses (2018 - 2025) Analysis & Trends
Cyclerion Therapeutics' Operating Expenses history runs 8 years deep, the most recent figure standing at $1.9 million for Q3 2025.
- In Q3 2025, Operating Expenses rose 42.28% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $5.2 million (down 7.89% YoY), while the FY2024 annual figure was $5.6 million, down 56.54% from the prior year.
- Operating Expenses for Q3 2025 stood at $1.9 million, up from $1.8 million in the prior quarter.
- The five-year high for Operating Expenses was $19.2 million in Q2 2021, with the low at $1.3 million in Q4 2024.
- The 5-year median for Operating Expenses is $3.3 million (2023), against an average of $6.3 million.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses sank 86.43% in 2023, then jumped 42.28% in 2025.
- Cyclerion Therapeutics' Operating Expenses stood at $14.9 million in 2021, then sank by 70.04% to $4.5 million in 2022, then tumbled by 59.71% to $1.8 million in 2023, then declined by 27.35% to $1.3 million in 2024, then surged by 44.25% to $1.9 million in 2025.
- Business Quant data shows CYCN's Operating Expenses at $1.9 million in Q3 2025, $1.8 million in Q2 2025, and $1.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 541.02 Mn |
| 10 | Cyclerion Therapeutics | 13.01 Mn | 9.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 6.02 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 3.28 Mn |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 4.52 Mn |
| Jun 30, 2022 | 13.74 Mn |
| Mar 31, 2022 | 13.70 Mn |
| Dec 31, 2021 | 14.87 Mn |
| Sep 30, 2021 | 11.63 Mn |
| Jun 30, 2021 | 19.18 Mn |
| Mar 31, 2021 | 13.46 Mn |
| Dec 31, 2020 | 19.36 Mn |